EGLN1 and preeclampsia: In contrast to mice with global Phd2 deficiency (18), the placental (conditional) Phd2 knockout (Phd2–/– cKO) is not embryonically lethal, making it a suitable preeclampsia model for examining anti-HIF-1A therapy.